Prolonged Cold Ischemia Time in Mouse Heart Transplantation Using Supercooling Preservation.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 3 1 2020
medline: 7 10 2020
entrez: 3 1 2020
Statut: ppublish

Résumé

Supercooling preservation techniques store a donor organ below 0°C without freezing. This has great advantages in inhibiting metabolism and preserving the organ in comparison to conventional preservation at 4°C. We developed a novel supercooling technique using a liquid cooling apparatus and novel preservation and perfusion solutions. The purpose of this study was to evaluate the preservation effect of our supercooling preservation technique in a mouse heart transplantation model. Syngeneic heterotopic heart transplantation was performed in 3 groups of mice: (1) the nonpreservation group, in which the cardiac grafts were transplanted immediately after retrieval; (2) the conventional University of Wisconsin (UW) group, in which the cardiac grafts were stored in UW solution at 4°C for different periods of time; and (3) the supercooling group, in which the cardiac grafts were stored in a novel supercooling preservation solution at -8°C for different periods of time. The maximal preservation time was investigated. Twenty-four-hour sample data were collected and analyzed to compare supercooling preservation to conventional UW preservation. Our technique yielded a stable -8°C supercooling state. Cardiac graft revival was successfully achieved after supercooling preservation for 144 hours, and long-term survival was observed after supercooling preservation for 96 hours. Posttransplant outcomes, including myocardial ischemia-reperfusion injury, oxidative stress-related damage, and myocardial cell apoptosis, were improved in comparison to conventional 4°C UW preservation. Supercooling heart preservation at -8°C greatly prolonged the preservation time and improved the posttransplant outcomes in comparison to conventional 4°C UW preservation. Supercooling preservation is a promising technique for organ preservation.

Sections du résumé

BACKGROUND
Supercooling preservation techniques store a donor organ below 0°C without freezing. This has great advantages in inhibiting metabolism and preserving the organ in comparison to conventional preservation at 4°C. We developed a novel supercooling technique using a liquid cooling apparatus and novel preservation and perfusion solutions. The purpose of this study was to evaluate the preservation effect of our supercooling preservation technique in a mouse heart transplantation model.
METHODS
Syngeneic heterotopic heart transplantation was performed in 3 groups of mice: (1) the nonpreservation group, in which the cardiac grafts were transplanted immediately after retrieval; (2) the conventional University of Wisconsin (UW) group, in which the cardiac grafts were stored in UW solution at 4°C for different periods of time; and (3) the supercooling group, in which the cardiac grafts were stored in a novel supercooling preservation solution at -8°C for different periods of time. The maximal preservation time was investigated. Twenty-four-hour sample data were collected and analyzed to compare supercooling preservation to conventional UW preservation.
RESULTS
Our technique yielded a stable -8°C supercooling state. Cardiac graft revival was successfully achieved after supercooling preservation for 144 hours, and long-term survival was observed after supercooling preservation for 96 hours. Posttransplant outcomes, including myocardial ischemia-reperfusion injury, oxidative stress-related damage, and myocardial cell apoptosis, were improved in comparison to conventional 4°C UW preservation.
CONCLUSIONS
Supercooling heart preservation at -8°C greatly prolonged the preservation time and improved the posttransplant outcomes in comparison to conventional 4°C UW preservation. Supercooling preservation is a promising technique for organ preservation.

Identifiants

pubmed: 31895334
doi: 10.1097/TP.0000000000003089
pii: 00007890-202009000-00022
doi:

Substances chimiques

Insulin 0
Organ Preservation Solutions 0
University of Wisconsin-lactobionate solution 0
Allopurinol 63CZ7GJN5I
Glutathione GAN16C9B8O
Adenosine K72T3FS567
Raffinose N5O3QU595M

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1879-1889

Références

Health Resources & Services Administration. Organ Donation Statistics. U.S. Government information on organ donation and transplantation website. Available at https://www.organdonor.gov/statistics-stories/statistics.html. Accessed September 1, 2018
Mancini D, Goldstein D, Taylor S, et al. Maximizing donor allocation: a review of UNOS region 9 donor heart turn-downs. Am J Transplant. 2017; 17123193–3198
Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia-reperfusion injury in liver transplantation–from bench to bedside. Nat Rev Gastroenterol Hepatol. 2013; 10279–89
Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation Transplant Rev. 1996; 102236–253
Latchana N, Peck JR, Whitson B, et al. Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature. J Thorac Dis. 2014; 681143–1149
Pietras C, Thomasson A, Gordon J, et al. Cardiac allograft survival stratified by preservation solution: a multi-institutional analysis J Heart Lung Transplant. 2018; 374S346
Li Y, Guo S, Liu G, et al. Three preservation solutions for cold storage of heart allografts: a systematic review and meta-analysis. Artif Organs. 2016; 405489–496
Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988; 454673–676
Giwa S, Lewis JK, Alvarez L, et al. The promise of organ and tissue preservation to transform medicine. Nat Biotechnol. 2017; 356530–542
Okamoto T, Nakamura T, Zhang J, et al. Successful sub-zero non-freezing preservation of rat lungs at -2 degrees C utilizing a new supercooling technology. J Heart Lung Transplant. 2008; 27101150–1157
Takahashi T, Kakita A, Takahashi Y, et al. Preservation of rat livers by supercooling under high pressure. Transplant Proc. 2001; 33Suppl 1–2916–919
Monzen K, Hosoda T, Hayashi D, et al. The use of a supercooling refrigerator improves the preservation of organ grafts. Biochem Biophys Res Commun. 2005; 3372534–539
Berendsen TA, Bruinsma BG, Puts CF, et al. Supercooling enables long-term transplantation survival following 4 days of liver preservation. Nat Med. 2014; 207790–793
Amir G, Horowitz L, Rubinsky B, et al. Subzero nonfreezing cryopreservation of rat hearts using antifreeze protein I and antifreeze protein III. Cryobiology. 2004; 483273–282
Kato H, Tomita S, Yamaguchi S, et al. Subzero 24-hr nonfreezing rat heart preservation: a novel preservation method in a variable magnetic field. Transplantation. 2012; 945473–477
Amir G, Rubinsky B, Basheer SY, et al. Improved viability and reduced apoptosis in sub-zero 21-hour preservation of transplanted rat hearts using anti-freeze proteins. J Heart Lung Transplant. 2005; 24111915–1929
Niimi M. The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon. J Heart Lung Transplant. 2001; 20101123–1128
Cai S, Hou J, Fujino M, et al. iPSC-derived regulatory dendritic cells inhibit allograft rejection by generating alloantigen-specific regulatory T cells Stem Cell Rep. 2017; 851174–1189
Hou J, Zhang Q, Fujino M, et al. 5-aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells. J Heart Lung Transplant. 2015; 342254–263
Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 97676–682
Cai S, Ichimaru N, Zhao M, et al. Prolonged mouse cardiac graft cold storage via attenuating ischemia-reperfusion injury using a new antioxidant-based preservation solution. Transplantation. 2016; 10051032–1040
Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun. 2003; 3043463–470
Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res. 2002; 553438–455
Friedrich MG. Myocardial edema–a new clinical entity? Nat Rev Cardiol. 2010; 75292–296
Seguchi R, Watanabe G, Kato H, et al. Subzero 12-hour nonfreezing cryopreservation of porcine heart in a variable magnetic field. Transplant Direct. 2015; 19e33
Goffart S, von Kleist-Retzow JC, Wiesner RJ. Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovasc Res. 2004; 642198–207
Stringham JC, Southard JH, Hegge J, et al. Limitations of heart preservation by cold storage. Transplantation. 1992; 532287–294
Pegg DE. The relevance of ice crystal formation for the cryopreservation of tissues and organs. Cryobiology. 2010; 60Suppl 3S36–S44
Nowak G, Ungerstedt J, Wernerson A, et al. Hepatic cell membrane damage during cold preservation sensitizes liver grafts to rewarming injury. J Hepatobiliary Pancreat Surg. 2003; 103200–205
Badet L, Petruzzo P, Lefrançois N, et al. Kidney preservation with IGL-1 solution: a preliminary report. Transplant Proc. 2005; 371308–311
Chen H, Quick E, Leung G, et al. Polyethylene glycol protects injured neuronal mitochondria Pathobiology. 2009; 763117–128
Luo J, Borgens R, Shi R. Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J Neurotrauma. 2004; 218994–1007
Valuckaite V, Seal J, Zaborina O, et al. High molecular weight polyethylene glycol (PEG 15-20) maintains mucosal microbial barrier function during intestinal graft preservation. J Surg Res. 2013; 1832869–875
Shi R. Polyethylene glycol repairs membrane damage and enhances functional recovery: a tissue engineering approach to spinal cord injury. Neurosci Bull. 2013; 294460–466
Malhotra R, Valuckaite V, Staron ML, et al. High-molecular-weight polyethylene glycol protects cardiac myocytes from hypoxia- and reoxygenation-induced cell death and preserves ventricular function. Am J Physiol Heart Circ Physiol. 2011; 3005H1733–H1742
Dutheil D, Underhaug Gjerde A, Petit-Paris I, et al. Polyethylene glycols interact with membrane glycerophospholipids: Is this part of their mechanism for hypothermic graft protection? J Chem Biol. 2009; 2139–49
Bruinsma BG, Berendsen TA, Izamis ML, et al. Supercooling preservation and transplantation of the rat liver Nat Protoc. 2015; 103484–494
Costanzo JP, do Amaral MC, Rosendale AJ, et al. Hibernation physiology, freezing adaptation and extreme freeze tolerance in a northern population of the wood frog. J Exp Biol. 2013; 216Pt 183461–3473
Larson DJ, Middle L, Vu H, et al. Wood frog adaptations to overwintering in Alaska: new limits to freezing tolerance. J Exp Biol. 2014; 217Pt 122193–2200
Grossman AN, Opie LH, Beshansky JR, et al. Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart. Circulation. 2013; 12791040–1048
Vlasselaers D. Glucose-insulin-potassium: much more than enriched myocardial fuel. Circulation. 2011; 1232129–130
Beattie GM, Crowe JH, Lopez AD, et al. Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes. 1997; 463519–523
Pu LL, Cui X, Fink BF, et al. Cryopreservation of adipose tissues: the role of trehalose. Aesthet Surg J. 2005; 252126–131
Di G, Wang J, Liu M, et al. Development and evaluation of a trehalose-contained solution formula to preserve hUC-MSCs at 4°C. J Cell Physiol. 2012; 2273879–884
Bean BP, Cohen CJ, Tsien RW. Lidocaine block of cardiac sodium channels. J Gen Physiol. 1983; 815613–642
Dobson GP, Letson HL. Adenosine, lidocaine, and Mg2+ (ALM): from cardiac surgery to combat casualty care–teaching old drugs new tricks. J Trauma Acute Care Surg. 2016; 801135–145
Rudd DM, Dobson GP. Eight hours of cold static storage with adenosine and lidocaine (adenocaine) heart preservation solutions: toward therapeutic suspended animation. J Thorac Cardiovasc Surg. 2011; 14261552–1561
Thatte HS, Rousou L, Hussaini BE, et al. Development and evaluation of a novel solution, Somah, for the procurement and preservation of beating and nonbeating donor hearts for transplantation. Circulation. 2009; 120171704–1713
Rivard AL, Gallegos R, Ogden IM, et al. Perfusion preservation of the donor heart: basic science to pre-clinical. J Extra Corpor Technol. 2009; 413140–148
Weber A, Murray JM. Molecular control mechanisms in muscle contraction. Physiol Rev. 1973; 533612–673
Hertl M, Chartrand PB, West DD, et al. The effects of hepatic preservation at 0 degrees C compared to 5 degrees C: influence of antiproteases and periodic flushing. Cryobiology. 1994; 315434–440
Leuvenink HG. Novel organ preservation methods: not only cool but supercool! Transplantation. 2015; 994647–648

Auteurs

Weitao Que (W)

Department of Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.

Xin Hu (X)

Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.

Masayuki Fujino (M)

Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Hayato Terayama (H)

Department of Anatomy, Division of Basic Medical Science, Tokai University School of Medicine, Kanagawa, Japan.

Kou Sakabe (K)

Department of Anatomy, Division of Basic Medical Science, Tokai University School of Medicine, Kanagawa, Japan.

Nahoko Fukunishi (N)

Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan.

Ping Zhu (P)

Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Shuang-Qin Yi (SQ)

Laboratory of Functional Morphology, Graduate School of Human Health Sciences, Tokyo Metropolitan University, Tokyo, Japan.

Yoshio Yamada (Y)

Technican Co., Ltd. Kanagawa, Japan.

Lin Zhong (L)

Department of Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Xiao-Kang Li (XK)

Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH